donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PKI PerkinElmer > Detailed Quotes

PKI PerkinElmer

144.090
-0.880-0.61%
Trading Session 06/28 11:33 ET
High
145.759
Open
144.520
Turnover
9.46M
Low
143.540
Pre Close
144.970
Volume
65.48K
Market Cap
18.18B
P/E(TTM)
23.58
52wk High
202.991
Shares
126.15M
P/E(Static)
17.83
52wk Low
132.780
Float Cap
18.12B
Bid/Ask %
0.00%
Historical High
202.991
Shs Float
125.76M
Volume Ratio
0.29
Historical Low
3.503
Dividend TTM
0.28
Div Yield TTM
2700
P/B
2.53
Dividend LFY
0.19%
Div Yield LFY
1873.83%
Turnover Ratio
0.05%
Amplitude
1.53%
Avg Price
144.482
Lot Size
1
Float Cap
18.12B
Bid/Ask %
0.00%
Historical High
202.991
Shs Float
125.76M
Volume Ratio
0.29
Historical Low
3.503
Dividend TTM
0.28
P/B
2.53
Dividend LFY
0.19%
Turnover Ratio
0.05%
Amplitude
1.53%
Avg Price
144.482
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
CEO: Singh Ph.D., Prahlad R.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...